earnings
DN
NASDAQ · DNLI
Denali Therapeutics Inc.
Healthcare · Biotechnology
$19.91
Down-$0.63 (-3.16%)
Updated Oct 6, 2026, 11:19 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -6
- Dividend yield
- 0.00%
- 52-week range
- $13.75 – $27.30
- Volume
- 1.72M
- Avg. volume
- 1.72M
Price performance · DNLI
DNLI price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
DNLI closed at $19.91 after 20 trading sessions, down 9.83% for the selected period.
- Last close
- $19.91
- Period change
- -9.83%
- Period low
- $19.72
- Period high
- $22.08
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $20.09 | $20.09 | $19.535 | $19.91 | 1.72M |
| Oct 2, 2026 | $20.85 | $20.85 | $19.9318 | $20.00 | 1.63M |
| Oct 1, 2026 | $20.55 | $20.85 | $20.40 | $20.53 | 1.94M |
| Sep 30, 2026 | $20.95 | $21.085 | $20.51 | $20.67 | 2.26M |
| Sep 29, 2026 | $20.88 | $21.01 | $20.41 | $20.81 | 1.39M |
| Sep 28, 2026 | $20.05 | $21.26 | $19.93 | $20.98 | 2.56M |
| Sep 25, 2026 | $20.46 | $20.595 | $19.9601 | $20.39 | 1.26M |
| Sep 24, 2026 | $20.40 | $20.64 | $19.725 | $20.47 | 2.27M |
| Sep 23, 2026 | $21.50 | $21.51 | $20.33 | $20.46 | 1.91M |
| Sep 22, 2026 | $20.755 | $21.79 | $20.47 | $21.60 | 2.34M |
| Sep 21, 2026 | $19.99 | $20.55 | $19.40 | $20.47 | 2.39M |
| Sep 18, 2026 | $20.07 | $20.155 | $19.56 | $19.72 | 2.96M |
| Sep 17, 2026 | $20.57 | $20.65 | $19.90 | $20.13 | 1.42M |
| Sep 16, 2026 | $20.40 | $20.51 | $19.87 | $20.06 | 1.86M |
| Sep 15, 2026 | $21.01 | $21.10 | $20.27 | $20.38 | 1.84M |
| Sep 14, 2026 | $21.09 | $21.58 | $20.96 | $21.22 | 1.07M |
| Sep 11, 2026 | $21.648 | $21.7916 | $21.055 | $21.09 | 1.24M |
| Sep 10, 2026 | $21.24 | $21.58 | $21.09 | $21.40 | 938.56K |
| Sep 9, 2026 | $21.69 | $22.06 | $21.34 | $21.57 | 2.09M |
| Sep 8, 2026 | $21.79 | $22.25 | $21.66 | $22.08 | 1.65M |
Latest DNLI news
The latest Smart Investors Daily articles mentioning DNLI.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…